Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05597267 · ClinicalTrials.gov registry record · NA
The MIRIA Acne Scar Study
A NA study of Acne Scars - Mixed Atrophic and Hypertrophic, sponsored by AVAVA.
- Active
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 3
- Study locations
NCT05597267: Active NA study of Acne Scars - Mixed Atrophic and Hypertrophic, sponsored by AVAVA.
NCT05597267 is a NA study of Acne Scars - Mixed Atrophic and Hypertrophic that is active but no longer recruiting, run by AVAVA. The registered enrollment target is 75 participants, below the 101-participant average among 7 other Acne Scars - Mixed Atrophic and Hypertrophic trials with a reported enrollment target (26% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05597267, a NA study of Acne Scars - Mixed Atrophic and Hypertrophic, is active but no longer recruiting, sponsored by AVAVA.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is being conducted to evaluate the performance and efficacy of the AVAVA MIRIA Laser Skin System treatment on acne scars. Participants will be treated with the MIRIA laser at least 4 times with each treatment spaced 4-6 weeks apart. The improvement of acne scars will be evaluated at 1 month and 3 months with a possibility of 6 months evaluation after the fourth treatment.
Primary Outcome
A 1 point or greater reduction in facial acne scars severity using the Echelle d'Evaluation Clinique des Cicatrices d'Acne (ECCA) Score ECCA Global Score Limits: Lowest Score (0) to Highest Score (540)
Conditions Studied
Interventions
- DEVICE MIRIA Laser
Study Locations (3)
Florida
- Enchantress Dermatology - Miami
Massachusetts
- AVAVA, Inc. - Waltham
New York
- Laser and Skin Surgery Center of New York - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2022-11-04 |
| Est. Completion | 2025-02-28 |
| Phase | NA |
What the registry record for NCT05597267 still lists
NCT05597267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 101-participant average among 7 other Acne Scars - Mixed Atrophic and Hypertrophic trials with a reported enrollment target (26% lower).
The record links to 1 condition, with Acne Scars - Mixed Atrophic and Hypertrophic appearing as the primary indexed condition, and to 1 intervention - of which MIRIA Laser is the first listed.
NCT05597267 reports a single indexed study location in Florida, Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT05597267 about?
NCT05597267 is a clinical study titled "The MIRIA Acne Scar Study". This study is being conducted to evaluate the performance and efficacy of the AVAVA MIRIA Laser Skin System treatment on acne scars. Participants will be treated with the MIRIA laser at least 4 times with each treatment spaced 4-6 weeks apart. The improvement of acne scars will be evaluated at 1 mon...
What is the current status of trial NCT05597267?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2022-11-04. Estimated completion is 2025-02-28.
What conditions does trial NCT05597267 study?
This clinical trial studies the following conditions: Acne Scars - Mixed Atrophic and Hypertrophic.
What interventions are being tested in trial NCT05597267?
The interventions under investigation include: MIRIA Laser (DEVICE).
Who is sponsoring clinical trial NCT05597267?
This trial is sponsored by AVAVA, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05597267 being conducted?
This trial has 3 study locations across Florida, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne Scars - Mixed Atrophic and Hypertrophic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color
RECRUITING · NA
-
AV-23-001 AVAVA MIRIA Pilot Study
ACTIVE NOT RECRUITING · NA
-
Tripeptide/Hexapeptide Topical and Hybrid Laser Treatment for Acne Scarring
COMPLETED · NA
-
enLighten Laser With MLA Handpiece for Treatment of Moderate and Severe Acne Scars
COMPLETED · NA
-
Functional Usability and Feasibility Testing of the Profound Matrix™ System
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI